The price of the ASC bargain with private equity: Viewpoint

Advertisement

The Business Corner is a bimonthly column by Shakeel Ahmed, MD, CEO of St. Louis-based Atlas Surgical Group.

Legend has it that Johann Georg Faust, a scholar hungry for more than ordinary life could offer, struck a deal with the devil. In exchange for his soul, he was granted wealth, power, knowledge and every worldly pleasure he desired.

The allure of private equity in the ASC space has reached a fever pitch, and frankly, it worries me. Over the last few years, I’ve sat in boardrooms and hallways, watching brilliant colleagues slide headfirst into the proverbial Faustian bargain. The pitch from these funds is always beautifully polished and deeply seductive: immediate liquidity, corporate scale, a mitigation of risk and a safety net against single-digit margins.

Remember, these are master salesmen. Much like Medusa or Kaa, they know how to hypnotize their audience into submission. But as someone who has spent a lifetime navigating the shifting economic tides of outpatient surgery, I look past the upfront windfalls. What I see underneath these leveraged buyouts is a quiet, dangerous erosion of the one thing that actually makes an ASC successful: absolute physician autonomy. And I promise you, that is the first thing you lose in these deals. 

The hard data entirely backs up my skepticism. If you look at the research published in JAMA Health Forum tracking the operational fallout of private equity acquisitions, the reality is sobering. While PE-backed health entities do see an average 11% increase in allowed claims and a notable spike in patient volume, that top-line expansion is rarely driven by clinical innovation or superior care. Instead, it is the programmatic result of aggressive, commercialized coding mechanics and strict cost-cutting protocols designed to feed a massive debt-servicing machine: A giant administrative ouroboros: a snake so busy eating its own tail that it sends everyone a bill for the privilege.

When a center trades its equity for institutional capital, its balance sheet changes overnight. The heavy debt utilized to fund these massive roll-ups chokes real operational cash flow, ultimately stripping the facility of its local agility. You are left with a corporate mandate for standardization that treats the operating room like an assembly line, pushing for high acuity just to satisfy a spreadsheet, regardless of the cascading overhead. This mandate slowly strips the surgeon of his true essence: A healer first, a businessman much later. 

Worse still, these bloated valuations create a structural paradox for the future of medicine. When a PE fund aggregates a sprawling multi-center footprint, the entry price for a young surgeon looking to buy into the facility skyrockets out of reach. By pricing out the next generation of talent, these deals effectively destroy the long-term culture of physician stewardship that built this outpatient industry from scratch.

We do not need to chase expansion for the sake of empty, sprawling growth. True excellence in outpatient surgery belongs to the lean, independent operator who answers to patients and peers, not institutional investors. I belong to that generation of investors. A debt-free balance sheet and a boardroom composed entirely of practicing physicians remain our ultimate competitive advantages. Before you sign away your operational flexibility for a short-term payout, look closely at what happens when the spreadsheets take over. True wealth isn’t a liquidation event that robs you of your legacy. It shouldn’t be. 

For years, Faust lived the life most people only dream about. But when the time came to settle the bargain, the devil returned to claim what Faust had promised. The initial rewards were extraordinary, but the consequences were devastating.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Leadership

Advertisement